Stock screenerAll disclosures →
EDGAR →
TAK
Conviction 94HealthcareScan · Thu, Sep 24, 2026Takeda Pharmaceutical Co Ltd (TAK) closed at $18.59 (-1.17%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 55, RS Rating 85, -2.4% from its 52-week high, +19.0% year to date. Sector: Healthcare · Drug Manufacturers - Specialty & Generic.
TAK$18.59-1.17%
ResistanceSupportVol 14Insider sell15
Vol MA14 2.37M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price18.59
Change-1.17%
Gap-1.12%
Rel volume1.69×
Avg volume2.25M
Avg $ vol41.71M
SMA 2018.50
SMA 5017.86
SMA 20017.05
Price vs 50+4.09%
Price vs 200+9.06%
MA stackbullish
50/200 cross—
Supertrendup · 18.15
RSI (14)55
MACD hist-0.02
MACD crossbear · 0d
Stoch %K / %D49 / 68
ADX (14)33
+DI / −DI31 / 21
RSI divergenceBearish
MACD divergence—
ATR %1.50%
ADR %1.12%
52w high19.05
52w low13.23
From 52w high-2.41%
Above 52w low+40.51%
New 52w highNo
SqueezeOff
Bollinger width7.11%
%B0.57
Donchian pos55.46%
Donchian high19.10
Donchian low17.96
AVWAP (52w high)18.85
vs AVWAP high-1.40%
AVWAP (52w low)16.65
vs AVWAP low+11.68%
OBV trendDown
Chaikin MF (20)-0.29
Today vs 20d1.69×
Avg vol (14d)2.37M
Avg vol (20d)2.25M
Avg $ vol (20d)41.71M
Market cap58.74B
RS Rating85 / 99
RS 3m (vs SPY)+14.29%
RS 6m (vs SPY)-15.18%
RS line new highNo
Trend template8/8
Technical rank70.3
1 week-2.41%
1 month+1.31%
3 months+18.79%
6 months+1.64%
1 year+23.44%
YTD+19.01%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target43.06
Target upside131.63%
Analyst ratingBuy
Institutional3.28%
Ent. value58.74B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNYSE
Shares out3.18B
Employees47.45K
ListedFri, Mar 7, 2008
Free float3.16B
Float %98.9%
Short interest4.09M
Days to cover1.8d
Short volume25.9%
Squeeze score20 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.48 vs $0.41
Last surprise+17.1% beat
Setup gradeA+
Conviction94 / 100
Pattern quality—
Tech rank70.3 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance19.07
Support16.79
Days since event—
Candle confirm—
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upJul 17 – Sep 23 scans
- Breaking out nowSep 31 scan
- Setting upSep 11 – Sep 233 scans
Recent news
- Trading the Move, Not the Narrative: (TAK) EditionStock Traders Daily · Wed, Sep 23, 2026
- Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and historyYahoo Finance Singapore · Tue, Sep 22, 2026
- Takeda Pharmaceutical stock holds at USD 18.91 as pipeline advancesAD HOC NEWS · Tue, Sep 22, 2026
- Takeda Pharmaceutical Company Limited (TAK) Latest Stock News & Headlines - Yahoo Financeca.finance.yahoo.com · Tue, Sep 22, 2026
- Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026Yahoo Finance · Tue, Sep 22, 2026
- Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 17.6% Potential Upside and Strong Revenue GrowthDirectorsTalk Interviews · Mon, Sep 21, 2026
- Takeda Stock Sinks Despite String Of Good NewsTipRanks · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in TAK
No recent disclosed trades by Congress in TAK. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TAK · open-market 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Duprey Lauren Rusckowski Chief Transformation Officer · American Depositary Shares · 2026-09-14 | Sell | 34.53K | $640K | 2026-09-14 | 2026-09-15 |
Plump Andrew Stewart President, R&D · American Depositary Shares · 2026-08-19 | Sell | 19.65K | $363K | 2026-08-19 | 2026-08-21 |
Greenway Nicola Deidre Petal Chief Human Resources Officer · American Depositary Shares · 2026-08-18 | Sell | 12.98K | $235K | 2026-08-18 | 2026-08-19 |
Shannon Elaine Mary Pres., Global Supply & Quality · American Depositary Shares · 2026-08-11 | Sell | 20.36K | $357K | 2026-08-11 | 2026-08-12 |
Furney Natalie Anne Marie Global General Counsel · American Depositary Shares · 2026-08-10 | Sell | 30.87K | $528K | 2026-08-10 | 2026-08-12 |
Greenway Nicola Deidre Petal Chief Human Resources Officer · American Depositary Shares · 2026-08-10 | Sell | 975 | $17K | 2026-08-10 | 2026-08-12 |
Greenway Nicola Deidre Petal Chief Human Resources Officer · American Depositary Shares · 2026-08-10 | Sell | 33.63K | $589K | 2026-08-10 | 2026-08-12 |
Greenway Nicola Deidre Petal Chief Human Resources Officer · American Depositary Shares · 2026-08-10 | Sell | 6.77K | $116K | 2026-08-10 | 2026-08-12 |
Ibrahim Ramy Riad Ahmed President, PDT BU · American Depositary Shares · 2026-08-10 | Sell | 7.28K | $124K | 2026-08-10 | 2026-08-12 |
Kim Julie So-Young President and CEO · American Depositary Shares · 2026-08-10 | Sell | 89.09K | $1.5M | 2026-08-10 | 2026-08-12 |
SEC filings
EDGAR filings in TAK · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.